MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1354750x.2018.1434681

Медицинская библиотека · Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2018

Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study.

Penn Andrew M, Bibok Maximilian B, Saly Viera K, Coutts Shelagh B, Lesperance Mary L, Balshaw Robert F, Votova Kristine, Croteau Nicole S, Trivedi Anurag, Jackson Angela M, Hegedus Janka, Klourfeld Evgenia, Yu Amy Y X, Zerna Charlotte, Borchers Christoph H, SpecTRA study group

Clinical StudyСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To derive a plasma biomarker protein panel from a list of 141 candidate proteins which can differentiate transient ischaemic attack (TIA)/minor stroke from non-cerebrovascular (mimic) conditions in emergency department (ED) settings.

DESIGN

Prospective clinical study (#NCT03050099) with up to three timed blood draws no more than 36 h following symptom onset. Plasma samples analysed by multiple reaction monitoring-mass spectrometry (MRM-MS).

PARTICIPANTS

Totally 545 participants suspected of TIA enrolled in the EDs of two urban medical centres.

OUTCOMES: 90-day, neurologist-adjudicated diagnosis of TIA informed by clinical and radiological investigations.

RESULTS

The final protein panel consists of 16 proteins whose patterns show differential abundance between TIA and mimic patients. Nine of the proteins were significant univariate predictors of TIA [odds ratio (95% confidence interval)]: L-selectin [0.726 (0.596-0.883)]; Insulin-like growth factor-binding protein 3 [0.727 (0.594-0.889)]; Coagulation factor X [0.740 (0.603-0.908)]; Serum paraoxonase/lactonase 3 [0.763 (0.630-0.924)]; Thrombospondin-1 [1.313 (1.081-1.595)]; Hyaluronan-binding protein 2 [0.776 (0.637-0.945)]; Heparin cofactor 2 [0.775 (0.634-0.947)]; Apolipoprotein B-100 [1.249 (1.037-1.503)]; and von Willebrand factor [1.256 (1.034-1.527)]. The scientific plausibility of the panel proteins is discussed.

CONCLUSIONS

Our panel has the potential to assist ED physicians in distinguishing TIA from mimic patients.

Для цитирования: Penn Andrew M, Bibok Maximilian B, Saly Viera K, Coutts Shelagh B, Lesperance Mary L, Balshaw Robert F, Votova Kristine, Croteau Nicole S, Trivedi Anurag, Jackson Angela M, Hegedus Janka, Klourfeld Evgenia, Yu Amy Y X, Zerna Charlotte, Borchers Christoph H, SpecTRA study group. Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study.. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2018. DOI: 10.1080/1354750x.2018.1434681.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.